Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension

It is widely accepted that impaired bioavailability of endothelial nitric oxide (NO) plays a critical role in the pathophysiology of pulmonary arterial hypertension (PAH). However, there are published data that show that relatively many PAH patients respond favorably to acetylcholine‐induced pulmona...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Mariko, Abe, Kohtaro, Oka, Masahiko, Saku, Keita, Yoshida, Keimei, Ishikawa, Tomohito, McMurtry, Ivan F., Sunagawa, Kenji, Hoka, Sumio, Tsutsui, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727286/
https://www.ncbi.nlm.nih.gov/pubmed/29208691
http://dx.doi.org/10.14814/phy2.13537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727286/
https://www.ncbi.nlm.nih.gov/pubmed/29208691
http://dx.doi.org/10.14814/phy2.13537

Ejemplares similares